Ikarian Capital »

Equillium shares owned by Ikarian Capital

Quarter-by-quarter ownership of Equillium (EQ) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Equillium

Tip: Access up to 7 years of quarterly data

All positions including Equillium held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Equillium by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $475k 332k 1.43

More positions owned by Ikarian Capital

United Therapeutics Corporation Put Option (UTHR)
Spdr Series Trust S&p Biotech Put Option (XBI)
Genmab A/s Sponsored Ads (GMAB)
Bristol Myers Squibb Put Option (BMY)
Abivax Sa Sponsored Ads (ABVX)
Uniqure Nv Call Call Option
Insmed Com Par $.01 (INSM)
Ptc Therapeutics I (PTCT)
Ionis Pharmaceuticals (IONS)
Cidara Therapeutics Com New (CDTX)
Scholar Rock Hldg Corp Put Option (SRRK)
Rapt Therapeutics Com New (RAPT)
Maze Therapeatics (MAZE)
Soleno Therapeutics (SLNO)
Cytokinetics Com New (CYTK)

View all positions for Ikarian Capital

Top funds holding Equillium

ADAR1 Capital Management
Adage Capital Partners GP
Decheng Capital
Woodline Partners
Standard Life Aberdeen
Balyasny Asset Management
Vanguard Group
Stempoint Capital
Takeda Pharmaceutical
Renaissance Technologies
Cantor Fitzgerald, L. P.
Ikarian Capital
Geode Capital Management
Diadema Partners
Hudson Bay Capital Management

View all funds holding Equillium